Bipolar disorder

...ba href=/bipolar disorder/a/b which we are developing with Pfizer, is progressing according to plan,” he said.

“The clinical program is due to be completed by the end of the year, while filing with the FDA in the United States is expected early in 2007.

We also expect to submit the file for sugammadex-a reversal agent used during general anesthesia-during the first half of next year.” Herm Cukier, Organon’s Executive Vice President of Global Marketing, went on to inform analysts that the company’s new fertility product (Org 36286), is planned for submission in 2008, with a new contraceptive (NOMAC/E2) expected to be filed in 2009 and an insomnia treatment (Org 50081) expected to be submitted in 2010.

Building on biotechnology and neuroscience Looking in more detail at human healthcare, analysts heard that the business will not only work to sustain leadership status in its traditional areas of gynecology (eg NuvaRing® and Livial®); fertility (Puregon Pen®/Follistim Pen®); and anesthesia (Esmeron®/Zemuron®); but will also focus on rebuilding its position in neuroscience.

“Our core indication areas provide a solid base with selected opportunities for growth, while in the medium and long-term, neuroscience provides us with interesting growth opportunities,” explained Organon’s Executive Vice President of Research and Development, David Nicholson.

“We are also building a biotechnology franchise as an additional long-term growth driver with ...

...ba href=/bipolar disorder/a/b who [i]are[/i] able to hold jobs, have families, live outwardly "normal" lives.

They may have Bipolar I, Bipolar II, cyclothymia or another variant.

And there are many who may seem "normal" most of the time who still suffer within themselves, whose lives are periodically interrupted by episodes, who perhaps don't speak to anyone else of their difficulties.

They may be "high functioning" - but they are still saddled with ba href=/bipolar disorder/a/b.

The narrow-minded attitude of the man who sent me this email displays the unfortunate tendency of the public to believe that there is only one kind of ba href=/bipolar disorder/a/b - the most severe kind.

In fact, the bipolar spectrum extends a long way from that particular pole.

Email to a FriendDisplay Latest Headlines Kids' Privacy Policy©2006 About, Inc., A part of The New York Times Comp...

...ba href=/bipolar disorder/a/b caused her to develop jerky movements and gain 50 pounds.

After suicide attempts and dismal reactions to the medication, and a descent into substance abuse that finally led her to the Betty Ford Center, she has found a psychiatrist she trusts — one who has tweaked her Effexor with a low dose of Wellbutrin.

After all, repeated research has shown that the most effective treatment for depression is medications along with psychotherapy.

With that approach, she is losing weight and has managed to get, and hold down, a job.

"Of course, if I knew then what I know now, so much pain could have been avoided," says Lindsey, who, like the other antidepressant users quoted in this story, did not want her last name used.

"I was feeling really hopeless in trying out all these different drugs and not having them work." As many patients learn, the key to effective treatment for depression — as with most illnesses — is giving the medications time to work and knowing when they aren't.

"What we should be doing is starting from the get-go and telling patients and families, you may not respond to this treatment alone," says University of Pittsburgh's Kupfer.

"We think we are allowed to use one drug, one bullet.

If we were treating cardiovascular disease or asthma, we would be talking about a treatment strategy over a lifetime." The newer, more measured view of antidepressants should not have been entirely unexpected, points out Fred Goodwin, the former head of th...